ArticleGut2021

Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.

Nannan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.